文献速递临床试验与 GCP

复苏后护理中的血压与氧合目标:一项随机临床试验的设计与统计分析计划

The "Blood pressure and oxygenation targets in post resuscitation care, a randomized clinical trial": design and statistical analysis plan.
PubMed 文献 · Trials · 2022-02-24

该研究为研究者发起的双中心随机临床试验,纳入心脏骤停复苏后昏迷的院外心脏骤停患者,采用1:1:1:1析因设计比较平均动脉压目标63 mmHg与77 mmHg、限制性(9-10 kPa)与宽松性(13-14 kPa)氧合目标,并设亚组干预比较36小时与72小时停用设备主动发热管理。主要终点为出院时神经功能不良(CPC 3或4级)或死亡。

要点

  • 双中心随机试验比较复苏后昏迷患者平均动脉压目标63与77 mmHg及限制性(9-10 kPa)与宽松性(13-14 kPa)氧合目标。
  • 亚组干预比较36小时与72小时停用设备主动发热管理。
  • 主要终点为出院时神经功能不良(CPC 3或4级)或死亡。

核心结论

  • 作者假设低或高目标血压及限制性或宽松性氧疗将通过降低缺氧性脑损伤的风险和程度影响死亡率。
  • 将在90天后评估神经学结局及生化和神经心理学测试。

研究设计与样本

  • 研究者发起的双中心随机临床试验,纳入收入重症心脏监护单元的院外心脏骤停昏迷患者。
  • 纳入标准为无意识、年龄大于18岁、自主循环恢复超过20分钟。
  • 按1:1:1:1分配至血压目标(平均动脉压63或77 mmHg,双盲干预)与氧合目标(限制性9-10 kPa或宽松性13-14 kPa)交叉组。
  • 亚组干预为设备主动发热管理在36小时或72小时后停止。
  • 所有患者接受依据国际指南的方案化标准治疗,包括36°C目标温度管理24小时、芬太尼和丙泊酚镇静及多模式神经预后评估。

主要发现

  • 主要终点为出院时神经功能不良(脑功能表现分类3或4级)或死亡,以先发生者为准。
  • 次要结局包括开始肾脏替代治疗或死亡的时间、48小时神经元特异性烯醇化酶水平、90天MOCA评分、3个月改良Rankin量表和CPC、90天NT-pro-BNP、90天eGFR和LVEF、ICU期间每日累积血管加压药需求及需要血管加压药联合正性肌力药或机械循环支持。

局限性

  • 试验注册为回顾性注册(2017年5月注册,ClinicalTrials.gov NCT03141099)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Comatose patients admitted after resuscitation from cardiac arrest have a significant risk of poor outcome due to hypoxic brain injury. While numerous studies have investigated and challenged the target temperature as the efficacious part of the guideline endorsed Targeted Temperature Management (TTM) protocols, our knowledge and how the remaining parts of the TTM are optimized remain sparse. The present randomized trial investigated two aspects of the TTM protocol: target blood pressure during the ICU stay and oxygenation during mechanical ventilation. Furthermore, the efficacy of device-based post-TTM fever management is addressed. METHODS: Investigator-initiated, dual-center, randomized clinical trial in comatose OHCA patients admitted to an intensive cardiac care unit. Patients are eligible for inclusion if unconscious, older than 18 years of age, and have return of spontaneous circulation for more than 20 min. INTERVENTION: allocation 1:1:1:1 into a group defined by (a) blood pressure targets in double-blind intervention targeting a mean arterial blood pressure of 63 or 77 mmHg and (b) restrictive (9-10 kPa) or liberal (13-14 kPa) of arterial oxygen concentration during mechanical ventilation. As a subordinate intervention, device-based active fever management is discontinued after 36 h or 72. Patients will otherwise receive protocolized standard of care according to international guidelines, including targeted temperature management at 36 °C for 24 h, sedation with fentanyl and propofol, and multimodal neuro-prognostication. Primary endpoint: Discharge from hospital in poor neurological status (Cerebral Performance category 3 or 4) or death, whichever comes first. SECONDARY OUTCOMES: Time to initiation of renal replacement therapy or death, neuron-specific enolase (NSE) level at 48 h, MOCA score at day 90, Modified Ranking Scale (mRS) and CPC at 3 months, NT-pro-BNP at 90 days, eGFR and LVEF at 90 days, daily cumulated vasopressor requirement during ICU stay, and need for a combination of vasopressors and inotropic agents or mechanical circulatory support. DISCUSSION: We hypothesize that low or high target blood pressure and restrictive and liberal oxygen administration will have an impact on mortality by reducing the risk and degree of hypoxic brain injury. This will be assessment neurological outcome and biochemical and neuropsychological testing after 90 days. TRIAL REGISTRATION: ClinicalTrials.gov NCT03141099. Registered on May 2017 (retrospectively registered).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kjaergaard J, Schmidt H, Møller JE, et al. The "Blood pressure and oxygenation targets in post resuscitation care, a randomized clinical trial": design and statistical analysis plan. Trials. 2022. PMID: 35209951. doi:10.1186/s13063-022-06101-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。